| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/18/1989 | EP0299745A2 Double-stranded RNA correction of RNase L deficiency |
| 01/18/1989 | EP0299707A2 Glycopeptide antibiotics |
| 01/18/1989 | EP0299706A2 Nonglycosylated plasminogen activator and method of preparation |
| 01/18/1989 | EP0299673A1 Rubella E1 glycoprotein antigens |
| 01/18/1989 | EP0299402A2 LHRH antagonists, their manufacture and pharmaceutical compositions thereof |
| 01/18/1989 | EP0299397A2 Peptides with vasorelaxing, natriuretic and diuretic activities, preparation process, agents containing them and their use |
| 01/18/1989 | EP0299376A2 Prostanoid compositions and methods for reducing blood vessel dysfunction |
| 01/18/1989 | EP0299354A2 Monoclonal antibodies against protein E7 of the human papilloma virus type 16, their production process and their use |
| 01/18/1989 | EP0299242A2 Heterologous viral peptide particle immunogens |
| 01/18/1989 | EP0299206A2 Recombinant human ADF |
| 01/18/1989 | EP0299205A1 Sustained release microcapsules and method for the production thereof |
| 01/18/1989 | EP0299057A1 Potentiation of cytotoxic conjugates |
| 01/18/1989 | EP0299053A1 Des-epidermal growth factor plasminogen activators |
| 01/18/1989 | EP0298990A1 Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive. |
| 01/18/1989 | EP0298989A1 Treatment of cancer with interferon and radiotherapy |
| 01/18/1989 | EP0082184B1 Nutritional composition for management of hepatic failure |
| 01/18/1989 | CN1030426A Superoxide dismutase derivatives, method of producing the same and medicinal uses of the same |
| 01/18/1989 | CN1030425A Pasteurizable, freeze-driable hemoglobin-based blood substitute |
| 01/17/1989 | USRE32833 Complementing set of monoclonal antibodies |
| 01/17/1989 | US4798885 Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain |
| 01/17/1989 | US4798827 Synergistin derivatives and pharmaceutical compositions which contain them |
| 01/17/1989 | US4798823 Immunosuppressive agents |
| 01/17/1989 | US4798821 Cyclic hexa; octa- and oligopeptides |
| 01/17/1989 | US4798806 Compositions and methods using a monoclonal antibody to a human T cell antigen |
| 01/17/1989 | US4798796 Cell lines and their use for the production plasminogen activators |
| 01/17/1989 | US4798787 Polyclonal |
| 01/17/1989 | CA1249100A1 Derivatives of peptides, their preparation, and compounds including them |
| 01/17/1989 | CA1248893A1 Murine hybridoma lym-1 and diagnostic antibody produced thereby |
| 01/17/1989 | CA1248892A1 Murine hybridoma lym-2 and diagnostic antibody produced thereby |
| 01/17/1989 | CA1248874A1 Process for the preparation of antitumoral glycoproteins modified on their carbohydrate units |
| 01/12/1989 | WO1989000200A1 Peptides and antibodies that inhibit platelet adhesion |
| 01/12/1989 | WO1989000199A1 Therapeutic antimicrobial polypeptides, their use and methods for preparation |
| 01/12/1989 | WO1989000198A1 Recombinant fibroblast growth factors |
| 01/12/1989 | WO1989000197A1 Improved processes for the treatment of vascular disease |
| 01/12/1989 | WO1989000194A1 Inhibition of eucaryotic pathogens and neoplasms and stimulation of fibroblasts and lymphocytes with lytic peptides |
| 01/12/1989 | WO1989000192A1 Production of kallikrein |
| 01/12/1989 | WO1989000191A1 Novel thrombolytic proteins |
| 01/12/1989 | WO1989000168A1 Novel interleukin-2 receptor and applications thereof |
| 01/12/1989 | WO1989000167A1 Proteins and protein compositions and their use |
| 01/12/1989 | WO1989000166A2 Growth hormone related peptide |
| 01/12/1989 | WO1989000161A1 Malic acid derivative containing renin inhibiting peptides |
| 01/12/1989 | WO1989000080A1 Gas inlet for a plurality of various reaction gases in reaction vessels |
| 01/12/1989 | WO1989000051A1 Fibrin-binding compound and method |
| 01/12/1989 | WO1989000049A1 Method and therapeutic compositions for the prevention of fibrin deposition or adhesions |
| 01/12/1989 | WO1989000048A1 Bactericidal and/or bacteriostatic peptides, process for their isolation, their production and their applications |
| 01/12/1989 | WO1989000045A1 Pellets with enzymatically controlled drug release |
| 01/12/1989 | WO1989000043A1 Ophthalmic agent and related compositions and method for treatment of the cornea |
| 01/12/1989 | WO1988009818A3 Growth hormone receptor |
| 01/12/1989 | WO1988009780A3 Polypeptide compounds having growth hormone releasing activity |
| 01/12/1989 | DE3820770A1 Polypeptides |
| 01/12/1989 | DE3721637A1 Gaseinlass fuer eine mehrzahl verschiedener reaktionsgase in reaktionsgefaesse Gas inlet for a plurality of different reactive gases in reaktionsgefaesse |
| 01/12/1989 | DE3721574A1 Arzneimittel in form von pellets mit enzymatisch kontrollierter arzneistoff-freisetzung Drug in the form of pellets with enzymatically controlled drug-release- |
| 01/11/1989 | EP0298875A1 Process for the selective extraction of the metallo-proteins of whey by adsorption and elution |
| 01/11/1989 | EP0298820A1 Peptide derivatives and their therapeutic application |
| 01/11/1989 | EP0298732A2 Therapeutic Somatostatin analogues |
| 01/11/1989 | EP0298723A1 Recombinant fibroblast growth factors |
| 01/11/1989 | EP0298633A2 Synthetic polypeptides |
| 01/11/1989 | EP0298555A1 Process for synthesis of aminomethylene phosphonoalkylphosphinates |
| 01/11/1989 | EP0298553A1 Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism |
| 01/11/1989 | EP0298474A2 Novel calcitonin derivative and salt thereof |
| 01/11/1989 | EP0298450A2 Hybridoma cell lines, monoclonal antibodies and their use for immunocytochemical detection or fluorescence-activated sorting of cells expressing the c-myb protein and pharmaceutical compositions |
| 01/11/1989 | EP0298436A2 Use of a vehicle with a high tumour affinity |
| 01/11/1989 | EP0298280A2 Animal derived cell with antigenic protein introduced therein |
| 01/11/1989 | EP0298135A1 Phenylalanine derivative and proteinase inhibitor |
| 01/10/1989 | US4797929 Word recognition in a speech recognition system using data reduced word templates |
| 01/10/1989 | US4797470 O-substituted tyrosyl dipeptide amides |
| 01/10/1989 | US4797469 Synthesis of hGRF (Somatocrinin) in liquid phase and intermediate peptides |
| 01/10/1989 | US4797388 Pharmaceutical compositions with galactitol as carrier |
| 01/10/1989 | US4797277 Method for reperfusion therapy |
| 01/10/1989 | US4797156 Metal treated by a solution containing ferric ferrous salt |
| 01/10/1989 | CA1248472A1 Monoclonal antibodies specific to in vivo fragments derived from fibrinogen |
| 01/10/1989 | CA1248449A1 Process for purifying factor viii: c |
| 01/10/1989 | CA1248448A1 PURIFICATION OF BIOLOGICALLY ACTIVE HUMAN IMMUNE INTERFERON-.gamma. |
| 01/10/1989 | CA1248447C Method of inactivating incompatibility-reaction- causing substances |
| 01/04/1989 | EP0298064A2 Birth control and diagnostic methods |
| 01/04/1989 | EP0297913A2 Production of Kallikrein |
| 01/04/1989 | EP0297882A2 Hybrid plasminogen activators |
| 01/04/1989 | EP0297860A1 Method and therapeutic compositions for the prevention of fibrin deposition or adhesions |
| 01/04/1989 | EP0297833A2 Physiologically active lymphotoxin |
| 01/04/1989 | EP0297816A2 Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents |
| 01/04/1989 | EP0297815A2 Fluorine containing renin inhibitors |
| 01/04/1989 | EP0297585A2 Neuronal polypeptide and methods of production and use thereof |
| 01/04/1989 | EP0297456A2 Immunosuppressant peptides |
| 01/04/1989 | EP0297436A2 Treatment of hyperhidrosis and ichthyosis |
| 01/04/1989 | EP0297362A2 Human aprotinine whose Lys residue in position 15 is substituted by another protogene redisue of amino-acid |
| 01/04/1989 | EP0297294A1 Process for preparing a solution with a high specific volume activity of a protein with a tissue plasminogen activator activity (t-PA), solution containing the protein with t-PA activity and use of the solution in human and veterinary medicine |
| 01/04/1989 | EP0297262A2 Synthetic gene coding for a growth factor |
| 01/04/1989 | EP0297159A1 [N-Acyl, 1,7-Di-Aline] calcitonins, method for their preparation, pharmaceutical compositions and use |
| 01/04/1989 | CN1030005A Process for selectirely extraction of metallo-proteins from lactoserum by adsorption and elution |
| 01/03/1989 | US4795806 Phospholipid affinity purification of Factor VIII:C |
| 01/03/1989 | US4795804 Polypeptide |
| 01/03/1989 | US4795744 Modulation of AIDS virus-related events by double-stranded RNAS |
| 01/03/1989 | US4795740 Antiviral peptides and means for treating herpes infections |
| 01/03/1989 | US4795739 Administering protein |
| 01/03/1989 | US4795636 Garlic |
| 01/03/1989 | CA1248299A1 Pharmaceutical compounds, preparation, use and intermediates therefor and their preparation |
| 01/03/1989 | CA1248298A1 Amino-thioalkyl structured radiation protection agents and their preparation |
| 01/03/1989 | CA1248296A1 Inhibitors of mammalian collagenase |
| 01/03/1989 | CA1248090A1 Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules |
| 01/03/1989 | CA1248089A1 Analgesic peptide and process for the preparation thereof |